Update 4/1/2010:
Drs. Erickson and McDougle have completed this pilot trial of Abilify in Fragile X, and have reported positive results at recent conferences. They are going forward with plans for a larger-scale trial. Abilify is an available drug which is currently used in some patients with Fragile X.

For details of the trial design please visit clinicaltrials.gov